Artificial intelligence is becoming a key focus for investors, even as global data points send a mixed message on growth, inflation, and interest rates. While some economies show cooler price pressures or firmer activity, others are dealing with weaker industry and trade, which keeps attention on productivity and efficiency. That is where the AI Stocks screener comes in, highlighting companies involved in chips, software, LLMs, cloud and broader AI transformation. In this article, you will see three of the most notable stocks from that screener and how each is positioned within this fast evolving theme.
Overview: Aura Consolidated Group (ASX:AXQ) provides a broad digital safety platform that covers credit monitoring, identity theft protection, online privacy tools, antivirus, password management, spam call protection, and device security for individuals, families, and employees in Australia and the United States, along with child online safety tools such as parental controls, gaming safeguards, and AI driven monitoring.
Operations: Aura Consolidated Group generates about US$192.52 million in annual revenue, all from security software and services in Australia.
Market Cap: A$1.06b
Investors interested in AI enabled security may consider Aura Consolidated Group, which reports revenue growth of 31.3% over the past year and offers a growing suite of AI powered tools under its Aura Intelligence platform for online safety and wellbeing. At the same time, there are clear pressure points, including ongoing losses, a P/S of 3.8x relative to peers, less than 1 year of cash runway, and a younger, non independent board. The recent IPO and senior hires in marketing and AI indicate management is pursuing scale, but the mix of growth potential and liquidity, governance, and valuation risks gives investors several factors to weigh carefully.
Rapid AI driven growth at Aura Consolidated Group is bumping up against losses, cash runway questions, and a 3.8x P/S, so it is worth reading the 1 key reward and 3 important warning signs (2 are major!)
Overview: Xero (ASX:XRO) provides cloud based accounting, payroll, payments, and tax software that helps small businesses and their advisors manage finances, billing, and compliance from a single online platform, supported by specialist tools such as Planday for workforce scheduling and Hubdoc for bills and receipts.
Operations: Xero generates about NZ$2.75b in revenue from providing online solutions for small businesses and their advisors, with key markets including Australia, New Zealand, the United Kingdom, the United States, and the Rest of World.
Market Cap: A$11.90b
Investors watching the rise of AI in everyday business software may want Xero on their radar, as it combines a large and growing cloud accounting base with AI driven tools like JAX, XeroForce, and Industry Benchmarks that aim to automate bookkeeping, cash flow decisions, and advisory insights for small businesses. The company already reports high gross margins around 88%, and new integrations with Microsoft 365, Anthropic, and partners such as Fresha and Wagepoint embed Xero deeper into clients’ workflows. At the same time, earnings have recently softened, net margins are modest at 6.1%, funding relies entirely on higher risk liabilities, and Xero trades on a high P/E. This raises the question of whether AI led efficiency and product depth can justify that growth story over time.
Xero’s high gross margins and AI tools like JAX and XeroForce could be masking a much bigger story about what its current P/E is really pricing in. Walk through the analyst forecasts for Xero to see what may be missing.
Overview: Echo IQ (ASX:EIQ) uses artificial intelligence to read echocardiogram data and flag patients at risk of structural heart disease, with its EchoSolv platform targeting conditions such as aortic stenosis, diastolic dysfunction, and heart failure, and it supports clinicians rather than replacing their judgment.
Operations: Echo IQ currently generates about A$0.09 million in revenue from the development of artificial intelligence software.
Market Cap: A$991.29 million
Echo IQ provides direct exposure to AI in healthcare diagnostics, focusing on structural heart disease where earlier risk detection can be critical. The company is still early stage with less than A$1 million in revenue, ongoing losses, and a very high P/B multiple, so expectations are already elevated and unprofitable operations add financing risk. Analysts currently forecast revenue growth for the company, and recent milestones such as the EchoSolv deployment at Mount Sinai and a research collaboration with Mayo Clinic position Echo IQ alongside globally recognised institutions. A sizeable A$110 million equity raise and the appointment of a CFO with deep medical and capital markets experience round out a story that many investors may want to understand in more depth.
Echo IQ’s tiny current revenue compared to its A$991.29 million market cap suggests expectations are already running hot, so walk through the analyst forecasts for Echo IQ to see what the market might still be missing
The three AI focused stocks covered here are just a starting point. The full screener has surfaced 14 more companies tied into chips, software, LLMs, cloud and broader ChatGPT related transformation stories through the Artificial Intelligence/ AI Stocks screener. Use Simply Wall St to identify and analyze the specific catalysts, financial traits and narratives that matter most to you so you can focus on the AI opportunities you have the highest conviction in.
If Xero or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Fresh stock ideas do not stay under the radar for long. Use these curated lists to spot potential breakouts before the crowd catches on, then act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com